MAPS now offers more than 800 degrees, skills courses and certifications to qualified employees, and pays the full course ...

Omniasecure, which was authorized for placement in the heart’s right ventricle, is the world’s smallest defibrillation lead, ...

Medtronic (NYSE: MDT) today announced a new interim analysis evaluating automated sacral neuromodulation (SNM) therapy.

The medical device giant is continuing to evolve its surgical training provision to chime with the dynamism necessary for ...

One-year clinical trial data for the next-generation, investigational, Sphere-360™ single-shot PFA catheter show impressive safety, performance, and efficiency results for paroxysmal AfibDual-energy ...

Medtronic plc , a global leader in healthcare technology, today announced positive clinical outcomes from two studies in atrial fibrillation (AFib) patients treated with the Afferatm family of ...

Medtronic , a global leader in healthcare technology, today announced that the Expand URO Investigational Device Exemption ...

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced it has submitted 510(k) applications to the U.S. Food and Drug Administration (FDA) seeking clearance for an ...

Latest approval expands Medtronic CGM portfolio in the U.S. GALWAY, Ireland, April 18, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced ...